Pub Date : 2025-11-01DOI: 10.1016/j.apjo.2025.100166
Fengbin Lin , Liu Li , Ping Lu , Li Tang , Yao Zhang , Lin Xie , Xiaomin Zhu , Guangxian Tang , Hengli Zhang , Lan Lu , Meichun Xiao , Jiangang Xu , Yunhe Song , Yuying Peng , Xiaoyan Li , Weirong Chen , Fengqi Zhou , Ningli Wang , Keith Barton , Ki Ho Park , Xiulan Zhang
Purpose
To evaluate the two-year outcomes of combined surgical peripheral iridectomy (SPI), goniosynechialysis (GSL), and goniotomy (GT) for advanced primary angle-closure glaucoma (PACG) without cataract.
Design
Multicenter prospective study.
Methods
The study included patients who received a combined SPI + GSL + GT for advanced PACG without cataract, all completed a 24-month follow-up. Outcome measures included changes in intraocular pressure (IOP), best-corrected visual acuity (BCVA), use of anti-glaucoma medications, surgical success, and postoperative complications over the 24-month period.
Results
A total of 63 eyes from 51 patients with advanced PACG were included in the study. Among these, 37 eyes (58.7 %) achieved complete success, and 55 eyes (87.3 %) achieved qualified success. The mean IOPs at baseline and after 24 months were 28.8 ± 7.51 mm Hg and 15.8 ± 4.40 mm Hg, respectively (P < 0.001). The average number of anti-glaucoma medications decreased from 1.9 ± 1.4–0.8 ± 1.2 over the 24-month period (P < 0.001). The overall BCVA was stable during the follow-up period (P = 0.225). The primary complications observed included IOP spike (n = 9), hyphema (n = 7), and shallow anterior chamber (n = 3), all of which occurred within the first month postoperatively. Regression analysis showed that older age was positively associated with both complete success [odds ratio (OR) = 1.05; P = 0.030] and qualified success (OR = 1.08; P = 0.024).
Conclusions
SPI + GSL + GT demonstrated safety and effectiveness in treating advanced PACG without cataract over the 24-month study period. This combined surgical approach should be considered a viable alternative to trabeculectomy for these patients.
{"title":"Two-year outcomes of combined surgical peripheral iridectomy, goniosynechialysis, and goniotomy for advanced primary angle-closure glaucoma without cataract: A multicenter study","authors":"Fengbin Lin , Liu Li , Ping Lu , Li Tang , Yao Zhang , Lin Xie , Xiaomin Zhu , Guangxian Tang , Hengli Zhang , Lan Lu , Meichun Xiao , Jiangang Xu , Yunhe Song , Yuying Peng , Xiaoyan Li , Weirong Chen , Fengqi Zhou , Ningli Wang , Keith Barton , Ki Ho Park , Xiulan Zhang","doi":"10.1016/j.apjo.2025.100166","DOIUrl":"10.1016/j.apjo.2025.100166","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the two-year outcomes of combined surgical peripheral iridectomy (SPI), goniosynechialysis (GSL), and goniotomy (GT) for advanced primary angle-closure glaucoma (PACG) without cataract.</div></div><div><h3>Design</h3><div>Multicenter prospective study.</div></div><div><h3>Methods</h3><div>The study included patients who received a combined SPI + GSL + GT for advanced PACG without cataract, all completed a 24-month follow-up. Outcome measures included changes in intraocular pressure (IOP), best-corrected visual acuity (BCVA), use of anti-glaucoma medications, surgical success, and postoperative complications over the 24-month period.</div></div><div><h3>Results</h3><div>A total of 63 eyes from 51 patients with advanced PACG were included in the study. Among these, 37 eyes (58.7 %) achieved complete success, and 55 eyes (87.3 %) achieved qualified success. The mean IOPs at baseline and after 24 months were 28.8 ± 7.51 mm Hg and 15.8 ± 4.40 mm Hg, respectively (P < 0.001). The average number of anti-glaucoma medications decreased from 1.9 ± 1.4–0.8 ± 1.2 over the 24-month period (P < 0.001). The overall BCVA was stable during the follow-up period (P = 0.225). The primary complications observed included IOP spike (n = 9), hyphema (n = 7), and shallow anterior chamber (n = 3), all of which occurred within the first month postoperatively. Regression analysis showed that older age was positively associated with both complete success [odds ratio (OR) = 1.05; P = 0.030] and qualified success (OR = 1.08; P = 0.024).</div></div><div><h3>Conclusions</h3><div>SPI + GSL + GT demonstrated safety and effectiveness in treating advanced PACG without cataract over the 24-month study period. This combined surgical approach should be considered a viable alternative to trabeculectomy for these patients.</div></div>","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":"14 6","pages":"Article 100166"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143530995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
East Asia is facing a growing burden of myopia, with pronounced disparities in access to eye care between urban and rural populations. Digital health technologies present a scalable and cost-effective alternative to traditional myopia interventions that enhance early detection, risk stratification, behavioral modification, and public education. Artificial intelligence-assisted screening tools, wearable monitors, and mHealth initiatives, such as the World Health Organization-International Telecommunication Union MyopiaEd program, have demonstrated effectiveness in improving myopia prevention and health education accessibility. However, achieving a sustained impact requires rigorous validation, robust data governance, infrastructure investment, and integration with established clinical strategies. East Asia could be well-positioned to pioneer a comprehensive digital model for equitable myopia control.
{"title":"Digital health as a scalable strategy for equitable myopia management in East Asia","authors":"Junhan Chen , Deokho Lee , Kazuno Negishi , Kazuo Tsubota , Toshihide Kurihara","doi":"10.1016/j.apjo.2025.100241","DOIUrl":"10.1016/j.apjo.2025.100241","url":null,"abstract":"<div><div>East Asia is facing a growing burden of myopia, with pronounced disparities in access to eye care between urban and rural populations. Digital health technologies present a scalable and cost-effective alternative to traditional myopia interventions that enhance early detection, risk stratification, behavioral modification, and public education. Artificial intelligence-assisted screening tools, wearable monitors, and mHealth initiatives, such as the World Health Organization-International Telecommunication Union MyopiaEd program, have demonstrated effectiveness in improving myopia prevention and health education accessibility. However, achieving a sustained impact requires rigorous validation, robust data governance, infrastructure investment, and integration with established clinical strategies. East Asia could be well-positioned to pioneer a comprehensive digital model for equitable myopia control.</div></div>","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":"14 6","pages":"Article 100241"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144940424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.apjo.2025.100193
Joanna Ng, Nazli Gul, Arjun Shrestha, Hong Kee Ng, Raymond N. Regalado, Rachel S. Chong
{"title":"Flourishing index measures among ophthalmologists in the Asia-Pacific region","authors":"Joanna Ng, Nazli Gul, Arjun Shrestha, Hong Kee Ng, Raymond N. Regalado, Rachel S. Chong","doi":"10.1016/j.apjo.2025.100193","DOIUrl":"10.1016/j.apjo.2025.100193","url":null,"abstract":"","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":"14 6","pages":"Article 100193"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143750363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.apjo.2025.100223
Poemen P. Chan , Xiulan Zhang , Tin Aung , Paul T.K. Chew , Nathan Congdon , Tanuj Dada , Seng Kheong Fang , Mingguang He , Chan Yun Kim , Jimmy S.M. Lai , Jacky W.Y. Lee , Yuanbo Liang , Vijaya Lingam , Catherine Y. Liu , Prin Rojanapongpun , Xinghuai Sun , Xin Tang , Clement C.Y. Tham
The Asia-Pacific Glaucoma Society (APGS), in collaboration with the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), convened a panel of 18 international experts from 10 countries/territories to identify areas of controversy and establish consensus on diagnosing and managing Acute Primary Angle Closure Attack (APACA). APACA is a relatively common and potentially vision-threatening ocular emergency, particularly in Chinese and Asian populations. With timely and appropriate intervention, favorable outcomes could be achieved. However, with the current treatment protocol, two areas need to be improved: 1) more rapid and consistent reduction of intraocular pressure (IOP), and 2) reducing the proportion of patients who develop chronic IOP elevation after resolution of an acute attack and successful laser peripheral iridotomy. The international panel of experts systematically revisited and debated alternative treatments to address the above issues. Consensus was evaluated using a five-point Likert scale (strongly agree, agree, neutral, disagree, and strongly disagree), in which each expert considered and voted anonymously and independently on each consensus statement. A statement consensus is established when the summation of votes for “agree” and “strongly agree” reaches a 75 % threshold. Argon laser peripheral iridoplasty, anterior chamber paracentesis, and laser pupilloplasty are considered appropriate and suitable options for rapid IOP reduction. Earlier phacoemulsification is effective in preventing further retinal ganglion cell loss and disease progression after APACA and is worth considering, provided adequate facilities and expertise are available. Further studies are warranted to evaluate the safety and efficacy of corneal indentation as a rapid and immediate treatment to lower IOP.
{"title":"Controversies, consensuses, and guidelines for acute primary angle closure attack (APACA) by the Asia-Pacific Glaucoma Society (APGS) and the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO)","authors":"Poemen P. Chan , Xiulan Zhang , Tin Aung , Paul T.K. Chew , Nathan Congdon , Tanuj Dada , Seng Kheong Fang , Mingguang He , Chan Yun Kim , Jimmy S.M. Lai , Jacky W.Y. Lee , Yuanbo Liang , Vijaya Lingam , Catherine Y. Liu , Prin Rojanapongpun , Xinghuai Sun , Xin Tang , Clement C.Y. Tham","doi":"10.1016/j.apjo.2025.100223","DOIUrl":"10.1016/j.apjo.2025.100223","url":null,"abstract":"<div><div>The Asia-Pacific Glaucoma Society (APGS), in collaboration with the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), convened a panel of 18 international experts from 10 countries/territories to identify areas of controversy and establish consensus on diagnosing and managing Acute Primary Angle Closure Attack (APACA). APACA is a relatively common and potentially vision-threatening ocular emergency, particularly in Chinese and Asian populations. With timely and appropriate intervention, favorable outcomes could be achieved. However, with the current treatment protocol, two areas need to be improved: 1) more rapid and consistent reduction of intraocular pressure (IOP), and 2) reducing the proportion of patients who develop chronic IOP elevation after resolution of an acute attack and successful laser peripheral iridotomy. The international panel of experts systematically revisited and debated alternative treatments to address the above issues. Consensus was evaluated using a five-point Likert scale (strongly agree, agree, neutral, disagree, and strongly disagree), in which each expert considered and voted anonymously and independently on each consensus statement. A statement consensus is established when the summation of votes for “agree” and “strongly agree” reaches a 75 % threshold. Argon laser peripheral iridoplasty, anterior chamber paracentesis, and laser pupilloplasty are considered appropriate and suitable options for rapid IOP reduction. Earlier phacoemulsification is effective in preventing further retinal ganglion cell loss and disease progression after APACA and is worth considering, provided adequate facilities and expertise are available. Further studies are warranted to evaluate the safety and efficacy of corneal indentation as a rapid and immediate treatment to lower IOP.</div></div>","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":"14 6","pages":"Article 100223"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144564318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.apjo.2025.100240
Zhixuan Wang , Zefeng Yang , Sujv Liu , Jinkun Liu , Chengjie Huang , Xiaoming Zhu , Guangfu Dang , Xiao Yang , Xiaojing Pan , Longfang Zhou , Guangxian Tang , Hengli Zhang , Sujie Fan , Liming Tao , Haijun Li , Aiguo Lv , Heting Liu , Jing Ren , Xiaowei Yan , Xiaoyan Li , Xiulan Zhang
Purpose
To evaluate the impact of prolonged use of topical glaucoma medications on the surgical outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in juvenile open-angle glaucoma (JOAG).
Patients and methods
This multicenter retrospective study included 100 eyes of 77 JOAG patients who underwent GATT with at least 12 months of follow-up. Patients were categorized into the short-duration (≤ 1.5 years) and long-duration (> 1.5 years) groups. Intraocular pressure (IOP), glaucoma medications, and complications were recorded at baseline and the final visit. Success was defined as a postoperative IOP ≤ 21 mmHg (criterion A), ≤ 18 mmHg (criterion B), or ≤ 15 mmHg (criterion C). Complete and qualified successes were defined as meeting these criteria without and with medications, respectively.
Results
The mean age of the participants was 23.2 ± 8.6 years with a mean follow-up of 14.2 ± 4.1 months.
Qualified and complete success rates for the short-duration and long-duration groups were 98.0 % and 92.0 % (P = 0.369), 80.0 % and 66.0 % (P = 0.322) for criterion A; 92.0 %, and 68.0 % (P = 0.006), 78.0 % and 50.0 % (P = 0.021) for criterion B; 66.0 % and 40.0 % (P = 0.013), 58.0 % and 30.0 % (P = 0.015) for criterion C. The short-duration group had a significantly lower final IOP than the long-duration group (P = 0.011). No significant differences were observed in final medication and complications.
Conclusions
Prolonged use of topical glaucoma medications may reduce the efficacy of GATT in achieving lower IOP in JOAG. Early surgical intervention may contribute to better postoperative outcomes.
{"title":"Evaluation of prolonged use of topical glaucoma medications on gonioscopy-assisted transluminal trabeculotomy outcomes in juvenile open-angle glaucoma","authors":"Zhixuan Wang , Zefeng Yang , Sujv Liu , Jinkun Liu , Chengjie Huang , Xiaoming Zhu , Guangfu Dang , Xiao Yang , Xiaojing Pan , Longfang Zhou , Guangxian Tang , Hengli Zhang , Sujie Fan , Liming Tao , Haijun Li , Aiguo Lv , Heting Liu , Jing Ren , Xiaowei Yan , Xiaoyan Li , Xiulan Zhang","doi":"10.1016/j.apjo.2025.100240","DOIUrl":"10.1016/j.apjo.2025.100240","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the impact of prolonged use of topical glaucoma medications on the surgical outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in juvenile open-angle glaucoma (JOAG).</div></div><div><h3>Patients and methods</h3><div>This multicenter retrospective study included 100 eyes of 77 JOAG patients who underwent GATT with at least 12 months of follow-up. Patients were categorized into the short-duration (≤ 1.5 years) and long-duration (> 1.5 years) groups. Intraocular pressure (IOP), glaucoma medications, and complications were recorded at baseline and the final visit. Success was defined as a postoperative IOP ≤ 21 mmHg (criterion A), ≤ 18 mmHg (criterion B), or ≤ 15 mmHg (criterion C). Complete and qualified successes were defined as meeting these criteria without and with medications, respectively.</div></div><div><h3>Results</h3><div>The mean age of the participants was 23.2 ± 8.6 years with a mean follow-up of 14.2 ± 4.1 months.</div><div>Qualified and complete success rates for the short-duration and long-duration groups were 98.0 % and 92.0 % (<em>P</em> = 0.369), 80.0 % and 66.0 % (<em>P</em> = 0.322) for criterion A; 92.0 %, and 68.0 % (<em>P</em> = 0.006), 78.0 % and 50.0 % (<em>P</em> = 0.021) for criterion B; 66.0 % and 40.0 % (<em>P</em> = 0.013), 58.0 % and 30.0 % (<em>P</em> = 0.015) for criterion C. The short-duration group had a significantly lower final IOP than the long-duration group (<em>P</em> = 0.011). No significant differences were observed in final medication and complications.</div></div><div><h3>Conclusions</h3><div>Prolonged use of topical glaucoma medications may reduce the efficacy of GATT in achieving lower IOP in JOAG. Early surgical intervention may contribute to better postoperative outcomes.</div></div>","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":"14 6","pages":"Article 100240"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144940408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.apjo.2025.100261
Victor T.T. Chan , Andrew C.Y. Mak , Rupesh Agrawal , Jyotirmay Biswas , Bahram Bodaghi , Carmen K.M. Chan , Soon-Phaik Chee , Wei Chi , Miguel Cordero-Coma , Vishali Gupta , Peter McCluskey , Danny S.C. Ng , Annabelle A. Okada , Carlos Pavesio , Uwe Pleyer , Sukhum Silpa-Archa , Justine R. Smith , Wenru Su , Ilknur Tugal-Tutkun , Peizeng Yang , Dennis S.C. Lam
Behçet’s disease remains a complex and challenging form of uveitis, marked by a high rate of relapse, significant inflammation, and a long-term risk of visual acuity loss. The introduction of biologics, especially anti-tumour necrosis factor (TNF) agents, has revolutionized treatment, significantly reducing sight-threatening complications and minimizing the adverse effects of steroid therapy. However, several challenges persist, including variable clinical presentations, a high incidence of vasculitis affecting both the retinal and systemic circulation, the recognition of neuro-Behçet’s disease, and the lack of tools for disease activity monitoring or biomarkers for diagnostic specificity and progression tracking. Additional issues such as the exit strategy for biologics and the cost-effectiveness of genetic testing further complicate its management. To address these complexities, the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII), and the Academia Retina Internationalis (ARI) formed a panel of 21 international experts from 11 countries and territories. This consensus manuscript reflects a systematic review of existing literature and the collective insights of these experts. The panel reviewed key topics, discussed controversies, and achieved consensus in areas including classification, diagnosis, systemic treatment, special groups such as pediatric or neuro-Behçet’s cases, and advancements in genetic stratification. Using a five-point Likert scale, 69 statements were evaluated, with 62 (89.9 %) achieving consensus. This paper aims to establish standardized guidelines to reduce variability and improve predictability in outcomes. For areas where consensus was not reached, ongoing research is essential to address these gaps and advance the management of Behçet’s disease-related uveitis.
{"title":"International consensuses and guidelines on managing ocular Behçet’s disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI)","authors":"Victor T.T. Chan , Andrew C.Y. Mak , Rupesh Agrawal , Jyotirmay Biswas , Bahram Bodaghi , Carmen K.M. Chan , Soon-Phaik Chee , Wei Chi , Miguel Cordero-Coma , Vishali Gupta , Peter McCluskey , Danny S.C. Ng , Annabelle A. Okada , Carlos Pavesio , Uwe Pleyer , Sukhum Silpa-Archa , Justine R. Smith , Wenru Su , Ilknur Tugal-Tutkun , Peizeng Yang , Dennis S.C. Lam","doi":"10.1016/j.apjo.2025.100261","DOIUrl":"10.1016/j.apjo.2025.100261","url":null,"abstract":"<div><div>Behçet’s disease remains a complex and challenging form of uveitis, marked by a high rate of relapse, significant inflammation, and a long-term risk of visual acuity loss. The introduction of biologics, especially anti-tumour necrosis factor (TNF) agents, has revolutionized treatment, significantly reducing sight-threatening complications and minimizing the adverse effects of steroid therapy. However, several challenges persist, including variable clinical presentations, a high incidence of vasculitis affecting both the retinal and systemic circulation, the recognition of neuro-Behçet’s disease, and the lack of tools for disease activity monitoring or biomarkers for diagnostic specificity and progression tracking. Additional issues such as the exit strategy for biologics and the cost-effectiveness of genetic testing further complicate its management. To address these complexities, the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII), and the Academia Retina Internationalis (ARI) formed a panel of 21 international experts from 11 countries and territories. This consensus manuscript reflects a systematic review of existing literature and the collective insights of these experts. The panel reviewed key topics, discussed controversies, and achieved consensus in areas including classification, diagnosis, systemic treatment, special groups such as pediatric or neuro-Behçet’s cases, and advancements in genetic stratification. Using a five-point Likert scale, 69 statements were evaluated, with 62 (89.9 %) achieving consensus. This paper aims to establish standardized guidelines to reduce variability and improve predictability in outcomes. For areas where consensus was not reached, ongoing research is essential to address these gaps and advance the management of Behçet’s disease-related uveitis.</div></div>","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":"14 6","pages":"Article 100261"},"PeriodicalIF":4.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145480554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-17DOI: 10.1016/j.apjo.2025.100249
Timothy Y Y Lai, Keiko Kataoka, Yi-Ting Hsieh, Rajendra S Apte, Muna Bhende, Andrew Chang, Voraporn Chaikitmongkol, Youxin Chen, Li Jia Chen, Gemmy C M Cheung, Jay Chhablani, Kenneth C S Fong, Robyn H Guymer, Fumi Gomi, Suber S Huang, Judy E Kim, Gregg T Kokame, Adrian Koh, Xiaoxin Li, Jennifer I Lim, Danny S C Ng, Annabelle A Okada, Nishant V Radke, Srinivas R Sadda, Mariko Sasaki, Sobha Sivaprasad, Mahesh P Shanmugam, Lalit Verma, Tien-Yin Wong, Xinyuan Zhang, Dennis S C Lam
{"title":"Corrigendum to \"International consensuses and guidelines on etiology, diagnosis, treatment, and future developments of neovascular age-related macular degeneration (nAMD) by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Ocular Imaging Society (APOIS) and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO)\" [Asia-Pac J Ophthalmol, Available online 29 August 2025, 100242 (2025) DOI:10.1016/j.apjo.2025.100242].","authors":"Timothy Y Y Lai, Keiko Kataoka, Yi-Ting Hsieh, Rajendra S Apte, Muna Bhende, Andrew Chang, Voraporn Chaikitmongkol, Youxin Chen, Li Jia Chen, Gemmy C M Cheung, Jay Chhablani, Kenneth C S Fong, Robyn H Guymer, Fumi Gomi, Suber S Huang, Judy E Kim, Gregg T Kokame, Adrian Koh, Xiaoxin Li, Jennifer I Lim, Danny S C Ng, Annabelle A Okada, Nishant V Radke, Srinivas R Sadda, Mariko Sasaki, Sobha Sivaprasad, Mahesh P Shanmugam, Lalit Verma, Tien-Yin Wong, Xinyuan Zhang, Dennis S C Lam","doi":"10.1016/j.apjo.2025.100249","DOIUrl":"https://doi.org/10.1016/j.apjo.2025.100249","url":null,"abstract":"","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":" ","pages":"100249"},"PeriodicalIF":4.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号